![Nissim Mashiach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nissim Mashiach
Directeur/Membre du Conseil chez
CYPHERPUNK TECHNOLOGIES INC.
Fortune : 190 687 $ au 31/05/2026
Profil
Nissim Mashiach is the founder of NuBiyota LLC, founded in 2013.
Current jobs include Director at Chemomab Ltd. and Independent Director at Cypherpunk Technologies, Inc. since 2017.
Former jobs include President & Chief Executive Officer at Macrocure Ltd. from 2012 to 2017, Independent External Director at MediWound Ltd., President & Chief Operating Officer at Omrix Biopharmaceuticals, Inc. from 1998 to 2011, General Manager at Ethicon, Inc. from 2009 to 2012, and Principal at Perio Products Ltd. in 1998.
Education includes an MBA from The University of Manchester, undergraduate studies at Technion-Israel Institute of Technology, and graduate studies at The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 168 750 ( 0,16 % ) | 190 688 $ | 31/05/2026 |
Postes actifs de Nissim Mashiach
| Sociétés | Poste | Début |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Directeur/Membre du Conseil | 01/01/2017 |
Chemomab Ltd.
 Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Nissim Mashiach
| Sociétés | Poste | Fin |
|---|---|---|
| MACROCURE LTD | Directeur Général | 01/01/2017 |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and devices for surgery | Corporate Officer/Principal | 01/01/2012 |
Perio Products Ltd.
 Perio Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/1998 |
Nubiyota LLC
 Nubiyota LLC BiotechnologyHealth Technology Develops a microbiome therapeutics platform | Fondateur | - |
| MEDIWOUND LTD. | Directeur/Membre du Conseil | - |
Formation de Nissim Mashiach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Omrix Biopharmaceuticals, Inc.
 Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and devices for surgery | Health Technology |
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
Perio Products Ltd.
Perio Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Develops a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers | Health Technology |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Nubiyota LLC
Nubiyota LLC BiotechnologyHealth Technology Develops a microbiome therapeutics platform | Health Technology |
